Two Tube Feeding Methods to Prevent Pneumonia After Severe Ischemic Stroke
Compares feeding into the intestine with feeding into the stomach after severe stroke.
Plain-language title generated from the registry record
Registry title: Gastric Feeding for the Prevention of Stroke-Associated Pneumonia
Key facts
- Where
- Nanjing, ChinaSee the site
- Phase
- Phase 4
Where in China
- Jinling Hospital, Medical School of Nanjing University, NanjingNanjing, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jinling Hospital, China
- Trial code
- NCT07630090
- Record updated
- 5 June 2026
- Original description
This randomized controlled trial aims to compare the effectiveness of early post-pyloric feeding versus gastric feeding in preventing SAP in patients with severe ischemic stroke. The main question to answer is whether post-pyloric feeding group is better than the gastric feeding group for preventing SAP.Read full original descriptionShow less
Comparing Early Post-pyloric Feeding Versus Gastric Feeding for the Prevention of Stroke-Associated Pneumonia in Patients With Severe Ischemic Stroke
This randomized controlled trial aims to compare the effectiveness of early post-pyloric feeding versus gastric feeding in preventing SAP in patients with severe ischemic stroke. The main question to answer is whether post-pyloric feeding group is better than the gastric feeding group for preventing SAP.
Inclusion: Age ≥ 18 years; Diagnosis of severe ischemic stroke, with NIHSS score > 16 [15-16]; Confirmed dysphagia via swallowing assessment (Kubota Water Swallowing Test ≥ grade 3, or confirmed aspiration risk by FEES/VFSS); Time from onset to enrollment ≤ 72 hours; Expected survival ≥ 7 days; Non-mechanically ventilated patients; Signed informed consent from patient or legal representative.
Exclusion: High risk of gastrointestinal bleeding or perforation; Advanced malignant tumor; Diagnosed with pneumonia upon admission; Intestinal obstruction or gastrointestinal obstruction; Severe liver or kidney dysfunction; Pregnancy or breastfeeding; Refusal to participate in the study.